12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CAT-2003: Phase I started

Catabasis began a 2-part, double-blind, placebo-controlled, U.S. Phase I trial of CAT-2003 in about 84 subjects. The first part will evaluate single ascending-doses of...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >